Experimental Drug P7C3-A20 Restores Memory in Mice With Advanced Alzheimer’s by Rebooting Vital Brain Energy Molecule

A study from Case Western Reserve shows the drug P7C3-A20 restores brain energy and memory in mice with late-stage Alzheimer’s by stabilizing NAD+ levels.

By: AXL Media

Published: Apr 30, 2026, 11:06 AM EDT

Source: Information for this report was sourced from Case Western Reserve University

Targeting the Energy Crisis Behind Cognitive Decline

A research team led by Andrew A. Pieper, M.D., Ph.D., at Case Western Reserve University and University Hospitals has challenged the long-held belief that advanced Alzheimer’s disease is a one-way path of neurological destruction. In a study published in Cell Reports Medicine, scientists identified a critical "energy crisis" in the brain fueled by the precipitous drop of nicotinamide adenine dinucleotide, or NAD+. This helper molecule is essential for moving energy within cells and repairing DNA, but its levels crash during the progression of Alzheimer’s. By treating symptomatic mice with an experimental compound called P7C3-A20, the team was able to stabilize this metabolic fuel, allowing neurons to regain function even after severe memory loss had already set in.

Functional Recovery Without the Clearance of Protein Plaques

The most striking outcome of the study was that the mice regained their ability to learn and recognize objects despite the continued presence of amyloid-beta plaques and tau tangles. Traditionally, Alzheimer's research has focused on clearing these protein clumps, yet the P7C3-A20 treatment suggests that the brain's "machinery" can be restarted if its energy balance is restored. In the experiments, 12-month-old mice with advanced disease symptoms performed as well as healthy control animals in navigation and recognition tests after six months of daily treatment. This finding shifts the focus from the debris left by the disease toward the underlying resilience and metabolic health of the surviving neurons.

Repairing the Brain’s Protective Blood-Vessel Lining

The experimental drug also demonstrated a remarkable ability to repair the blood-brain barrier, the critical filter that prevents toxic substances and immune cells from leaking into brain tissue. In Alzheimer’s patients, this barrier often becomes "leaky," leading to chronic inflammation that further damages delicate neural circuits. Microscope imaging revealed that the NAD+-stabilizing drug tightened the seals of the vessel linings, significantly reducing immune leakage and neuroinflammation. By calming the internal environment of the brain and limiting oxidative stress, the therapy provided a stable platform for memory circuits to function and repair themselves effectively.